The Truth About MMR: What Actually Changed (and What Didn't)
LISTEN ON APPLE PODCASTS | LISTEN ON SPOTIFY | LISTEN ON AMAZON MUSIC
A headline can be technically accurate and still leave you with an entirely wrong impression. That gap — between what a story actually says and what a reader walks away believing — is what pulled Dr. Lara Baatenburg and David Roden into this conversation. The trigger was a year's worth of MMR vaccine headlines. The actual subject is bigger than any one vaccine: how information gets distorted on its way from a policy meeting to your phone.
A note before diving in: this isn't an argument for or against the MMR vaccine. It's an attempt to separate what changed from what didn't, and to look honestly at why so much confusion built up around it.
Fifty years, not new
MMR stands for measles, mumps, and rubella — a trivalent vaccine, meaning three vaccines combined into one shot. The individual measles vaccine dates to 1963; the combined MMR version has existed since 1971. It's a two-dose series — one shot at 12 to 15 months, a second at four to six years — added specifically because efficacy climbs from roughly 93% after the first dose to about 97% after the second.
That's over five decades of use, studied in millions of children through multiple Cochrane reviews and a substantial body of ongoing research. The safety profile is well established. Serious harms are rare; febrile seizures carry a documented but small risk, and they occur in children independent of vaccination as well. No causal link to autism has been found in the research record.
What actually changed
In June 2025, the Department of Health and Human Services restructured the CDC's Advisory Committee on Immunization Practices, replacing its 17 sitting members with new appointees. Three months later, that reconstituted panel voted 8–3 on a specific, narrower change: no longer recommending the MMRV vaccine — the four-in-one version that adds a varicella (chickenpox) component — for a child's first dose. The reasoning: MMRV's first dose carries a slightly elevated febrile seizure risk compared to giving MMR and the varicella vaccine separately. That elevated risk doesn't appear at the second dose.
That's it. That's what changed. The standalone MMR recommendation was not altered.
Where the confusion actually came from
If the only change was a narrow MMRV dosing recommendation, why did so many people come away believing HHS had pulled back on MMR broadly? Public statements from RFK Jr. are a significant part of the answer. Some of what he's said publicly about the vaccine doesn't hold up against the data — claims about the vaccine's effectiveness fading around 4.5% per year, or MMR causing meaningful annual death counts. Neither claim is supported by the research record. The vaccine has demonstrated durable, long-term effectiveness, and serious adverse outcomes are rare, occurring primarily in immunocompromised individuals given that MMR is a live vaccine.
The same public figure has, on the same day in some instances, publicly affirmed that MMR is the most effective way to prevent measles spread — while also promoting unproven treatments cited from a small, uncontrolled case series. That inconsistency, playing out on a public stage, is a large part of why the actual policy change and the public perception of what happened diverged so widely.
The outbreak underneath all of this
None of this is happening in a vacuum. Measles cases in the U.S. have topped 2,100 this year, with roughly 93% occurring in unvaccinated individuals and three confirmed deaths. The United States had previously achieved measles elimination status; that status has now been lost due to sustained transmission.
Herd immunity against measles requires roughly 95% vaccination coverage. National kindergarten MMR coverage currently sits around 92.5% — below that threshold, which tracks with the outbreak pattern being observed. A newer proposal to split the combined MMR vaccine into three separate shots has also surfaced, without any published data offered to justify the change — and practically speaking, no manufacturer currently produces the individual measles, mumps, or rubella vaccines as standalone products, so there's presently no way for a parent to act on that proposal even if they wanted to.
Reading past the headline
The deeper lesson of this episode isn't really about vaccines specifically — it's about media literacy. Headlines are written to generate clicks, not to convey nuance, and the incentive structure behind that is straightforward: more clicks mean more ad revenue, regardless of whether the reader ever finishes the article. The most inflammatory version of a claim tends to sit in the headline; the accurate, hedged, carefully qualified version tends to live several paragraphs into the body text, partly because publications have their own legal incentive to soften claims once they get into specifics.
Most people never make it that far. The gap between what a headline implies and what the full article actually supports is exactly where misinformation takes root — not necessarily through fabrication, but through selective emphasis and public statements that don't always match the underlying data.
Healthy skepticism versus outrage
There's an important distinction between reasonable skepticism and reflexive distrust. Skepticism grounded in evidence, logic, and a willingness to actually examine data is healthy — genuinely useful, even. What's different is outrage content: sweeping claims made with no supporting evidence, designed to provoke a reaction rather than inform a decision. Both David and Dr. Lara acknowledge getting pulled into questionable narratives themselves at points, particularly during COVID, before recognizing when a source had drifted from evidence-based reasoning into fear-driven speculation.
Evaluating a single epidemiological study as definitive proof of anything is one common trap — a single study can raise a good question; it rarely settles one, especially when it stands against a much larger body of contradicting research. Understanding how to actually read clinical research, including its limitations, is a skill, and most public vaccine debate happens without either side really having it.
What to actually do with a headline like this
The practical takeaway is straightforward, if not always convenient: read past the headline before forming an opinion, and be skeptical of both extremes — reflexive dismissal of any concern, and uncritical amplification of any claim. Public health officials and media outlets carry real responsibility here too. Statements made without clear evidentiary backing shape public understanding regardless of whether they hold up under scrutiny, and that responsibility doesn't disappear just because a claim eventually gets walked back in paragraph nine of an article nobody read that far into.
If you have specific questions about MMR, MMRV, or any vaccine for your child or yourself, that conversation belongs with your own physician — not with a headline, and not with a comment section.
Vitals & Values is the podcast of Concierge Medicine of West Michigan, hosted by Dr. David Roden and Dr. Lara Baatenburg. New episodes available wherever you listen.
